Terrie Curran - Insider Trading & Ownership

Location
C/O Myovant Sciences Inc., 320 West 37 Th Street, 5 Th Floor, New York, NY
Summary
The estimated net worth of Terrie Curran is at least $2.65M dollars as of June 16, 2025. Terrie Curran is the President and Chief Executive, Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $2.4M. Terrie Curran is the Director of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $245K.
Signature
/s/ Latha Vairavan, as Attorney-in-Fact for Terrie Curran
All Insider Reports
All Insider Reports

Ownership of Terrie Curran

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PHAT Phathom Pharmaceuticals, Inc. President and Chief Executive, Director $2.4M -$126K -4.98% Feb 27, 2025
ARQT Arcutis Biotherapeutics, Inc. Director $245K -$94.2K -27.8% Jun 12, 2025
MYOV Myovant Sciences Ltd. Director Mar 10, 2023

Insider Transactions Reported by Terrie Curran:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.